EVERLON SYNTHETICS LTD. (EVERLON) Fair Value & Analysis
Consumer Discretionary · IN · Market cap ₹885M
Strengths
Risks
Fair value as of: Aug 25, 2026
From 24 valuation models · updated 2 days ago
Fair value updated Aug 25, 2026, revised from ₹24.87 to ₹22.83 (−8.2%) since Aug 13, 2026. Share price −1.4% over the past month.
Below-average quality, and trading another 364% above our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (₹29.67). The favourable scenario is already priced in.
- Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 25, 2026.
How to read this chart
60‑month range ₹8.90 – ₹210.72 · fair‑value band ₹17.12 – ₹29.67 · the ₹105.90 price screens above the ₹22.83 fair value. Dashed = 300-day average. As of Aug 25, 2026.
Analysis
EVERLON SYNTHETICS LTD. (EVERLON) currently trades at ₹105.90, while our model-based Fair Value estimate is ₹22.83, implying the stock looks roughly 78.4% overvalued today. The Quality Score stands at 46/100 (below-average quality), in the Consumer Discretionary sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Net debt stands at ₹43.2M. The stock trades on a trailing P/E of 74.4 (as of Aug 25, 2026). Fundamentals as of Aug 25, 2026
Our scenario range runs from ₹17.12 (bear case) to ₹29.67 (bull case); at ₹105.90, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 37% above its 52-week low. For context, the median of 10 Consumer Discretionary peers we cover trades at -19% fair-value upside, at -78%, EVERLON screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (₹45.86) versus Earnings-Based (₹14.85). Highest evidence: Growth DCF (80).
Notify me when EVERLON reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 25, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 46 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
EVERLON SYNTHETICS LTD. reported revenue of ₹131M in FY2025 versus ₹340M in FY2021, a compound −21.2%/yr. Reported net income was ₹11.9M in FY2025, compounding +94.6%/yr from FY2021.
EVERLON screens 78% overvalued. Compare with RAJPALAYAM →
Peer Group
Textiles · 24 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Textiles median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Textiles stocks, each showing price versus our Fair Value estimate (as of Aug 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| RAJPALAYAM RAJPALAYAM | ₹823.35 | ₹1,694 | +106% |
| LAKSHMIMIL LAKSHMIMIL | ₹8,086 | ₹1,351 | -83% |
| OMNITEX OMNITEX | ₹737.70 | ₹108.11 | -85% |
| RNBDENIMS RNBDENIMS | ₹8.66 | ₹15.60 | +80% |
| CANDOUR CANDOUR | ₹68.52 | ₹20.30 | -70% |
| LAHOTIOV LAHOTIOV | ₹45.15 | ₹52.51 | +16% |
| PREMCO PREMCO | ₹381.00 | ₹307.99 | -19% |
| AICHAMP AICHAMP | ₹28.45 | ₹9.86 | -65% |
| DEEPAKSP DEEPAKSP | ₹129.60 | ₹86.07 | -34% |
| KGPETRO KGPETRO | ₹165.25 | ₹144.94 | -12% |
Compare EVERLON SYNTHETICS LTD. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is EVERLON SYNTHETICS LTD. (EVERLON) overvalued or undervalued?
What is the fair value of EVERLON?
What is the quality score of EVERLON?
What is the net profit margin of EVERLON?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Watch EVERLON SYNTHETICS LTD. in the live analysis
One click puts EVERLON SYNTHETICS LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.